戻る Agenda
LS22: Ways to Reduce Hurdles for Clinical Trial Participation by Conducting Good Participatory Practice Workshop Part 1
Session Chair(s)
Junko Sato, PhD
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Tatsuo Iiyama, MD
National Center for Global Health and Medicine, Japan
Director, Department of International Trial (DIT)
Takayuki Imaeda, MPharm, MS
Pfizer R&D Japan, Japan
Head of Regulatory Sciences